Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2).
Peters S, Galle PR, Bernaards CA, Ballinger M, Bruno R, Quarmby V, Ruppel J, Vilimovskij A, Wu B, Sternheim N, Reck M.
Peters S, et al. Among authors: bruno r.
Clin Transl Sci. 2022 Jan;15(1):141-157. doi: 10.1111/cts.13149. Epub 2021 Sep 28.
Clin Transl Sci. 2022.
PMID: 34582105
Free PMC article.